Indication
Methemoglobinemia
Methemoglobinemia is a hematologic disorder characterized by an abnormal accumulation of methemoglobin in circulating erythrocytes, leading to impaired systemic oxygen delivery and functional anemia. Read more about Methemoglobinemia
11 drugs 10 manufacturers
Drugs that treat it
Common Methemoglobinemia therapies.
METHYLENE BLUE (ANTIDOTE) (methylene blue)
PROVAYBLUE (methylene blue)
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
METHYLENE BLUE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMethemoglobinemia is a hematologic disorder characterized by an abnormal accumulation of methemoglobin in circulating erythrocytes, leading to impaired systemic oxygen delivery and functional anemia.
Pathophysiologically, the condition occurs when heme iron is oxidized from its functional ferrous state to the ferric state, which prevents affected subunits from binding oxygen and shifts the oxygen dissociation curve of remaining normal hemoglobin to the left.
It can be congenital due to enzymatic deficiencies or hemoglobin mutations, but it most frequently arises as an acquired condition secondary to exposure to oxidizing drugs or toxins, with infants exhibiting heightened vulnerability.
Characteristic clinical manifestations include central cyanosis that is refractory to supplemental oxygen, chocolate-brown discoloration of arterial blood, fatigue, and tissue hypoxia that can progress to cardiac arrhythmias, seizures, or death at severe levels.
- nih.gov
Methemoglobinemia is a hematologic disorder characterized by an abnormal accumulation of methemoglobin in circulating erythrocytes, leading to impaired systemic oxygen delivery and functional anemia Pathophysiologically, the condition occurs when heme iron is oxidized from its functional ferrous state to the ferric state, which prevents affected subunits from binding oxygen and shifts the oxygen dissociation curve of remaining normal hemoglobin to the left It can be congenital due to enzymatic d...
- nih.gov
Methemoglobinemia is a hematologic disorder characterized by an abnormal accumulation of methemoglobin in circulating erythrocytes, leading to impaired systemic oxygen delivery and functional anemia
- nih.gov
It can be congenital due to enzymatic deficiencies or hemoglobin mutations, but it most frequently arises as an acquired condition secondary to exposure to oxidizing drugs or toxins, with infants exhibiting heightened vulnerability
- nih.gov
It can be congenital due to enzymatic deficiencies or hemoglobin mutations, but it most frequently arises as an acquired condition secondary to exposure to oxidizing drugs or toxins, with infants exhibiting heightened vulnerability
- nih.gov
Characteristic clinical manifestations include central cyanosis that is refractory to supplemental oxygen, chocolate-brown discoloration of arterial blood, fatigue, and tissue hypoxia that can progress to cardiac arrhythmias, seizures, or death at severe levels
Personalize your experience
Follow Methemoglobinemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.